ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.72
0.56%
US Tech 100
17,658.00
0.32%
S&P 500
5,214.08
0.51%
US Dollar vs CAD
1.36885
0.08%
Bitcoin
62,852.68
-0.31%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. AgeX Therapeutics Inc (AGE)

  7. AgeX Therapeutics Inc (AGE) News

AGE

AgeX Therapeutics (AGE)

AgeX Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:AGE
DateTimeSourceHeadlineSymbolCompany
03/22/20244:27PMGlobeNewswire Inc.AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
03/07/20243:49PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsAMEX:AGEAgeX Therapeutics Inc
03/07/20243:47PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
03/07/20246:47AMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
02/14/20243:01PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
02/13/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AGEAgeX Therapeutics Inc
02/06/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
02/05/20246:19AMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
01/19/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
01/18/20244:29PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:AGEAgeX Therapeutics Inc
01/17/20243:19PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
01/16/20248:11AMEdgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]AMEX:AGEAgeX Therapeutics Inc
01/11/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
01/09/20243:16PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
01/05/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
12/28/20233:02PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
12/18/20233:25PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
12/13/20234:11PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
12/08/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
12/01/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
11/17/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
11/16/20233:01PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
11/15/20238:38AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AGEAgeX Therapeutics Inc
11/14/20233:25PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
11/14/20233:05PMBusiness WireAgeX Therapeutics Reports Third Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
11/07/20233:06PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AGEAgeX Therapeutics Inc
11/07/20233:05PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AGEAgeX Therapeutics Inc
11/06/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
11/01/20233:28PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
10/06/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
 Showing the most relevant articles for your search:AMEX:AGE

Your Recent History

USOTC
EMGE
Emergent Health (PK)
USOTC
TXTM
ProText Mobility (PK)
USOTC
SONG
Music Licensing (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
RDAR
Raadr (PK)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
CLNV
Clean Vision (QB)
USOTC
YCRM
Yuenglings Ice Cream (PK)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
BABL
Buildablock (PK)
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved